FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation

Honghong Zhou; Yongshuo Liu; Ruigong Zhu; Fang Ding; Yong Wan; Y Li; Zhihua Liu

doi:10.1038/onc.2016.479

FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation

Honghong Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongshuo Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ruigong Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Fang Ding(Chinese Academy of Medical Sciences & Peking Union Medical College), Yong Wan(University of Pittsburgh), Y Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhihua Liu(Chinese Academy of Medical Sciences & Peking Union Medical College)

Oncogene

January 9, 2017

10.1038/onc.2016.479

Cited by 103Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis